Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis

Autor: Laura Fernández, Shaden Kamhawi, Luigi Gradoni, Rhea N. Coler, Eugenia Carrillo, Jose M. Requena, Jesus G. Valenzuela, Begoña Pérez-Cabezas, Anabela Cordeiro-da-Silva, Fabiano Oliveira, Pedro Cecílio, Epifanio Fichera, Gaurav Gupta, Reinhard Glueck, Javier Moreno, Steven G. Reed

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
PLoS Neglected Tropical Diseases, Vol 11, Iss 11, p e0005951 (2017)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Repisalud
Instituto de Salud Carlos III (ISCIII)
PLoS Neglected Tropical Diseases

The notion that previous infection by Leishmania spp. in endemic areas leads to robust anti-Leishmania immunity, supports vaccination as a potentially effective approach to prevent disease development. Nevertheless, to date there is no vaccine availa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc24427e1962ea8acbe750fc9b061033
http://hdl.handle.net/10261/166367